“…Cho et al. 31 reported that only 27 patients with advanced CKD and kidney failure were treated in the first 10 months since the emergency use authorization. Our findings, in conjunction with the ongoing clinical trial (Phase I: NCT05487040 ), can help fill a critical knowledge gap regarding the effectiveness of oral antivirals in the CKD population.…”